It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
Trump hush money trial: Prosecutors move deeper into ex
VOX POPULI: The war in Ukraine enters its 3rd year with no end in sight
Hong Kong launches nightlife campaign to boost 'night
Trump's strategist push AI to help conservatives, all you need to know
VOX POPULI: Some celebrate while others ponder time and space on leap day
VOX POPULI: ‘Domicide’ is yet another terrible addition to the lexicon of war
Hainan island: Known as 'China's Hawaii,' the vacation hotspot is also a strategic military base
Donald Trump calls Joe Biden weak on antisemitism, ignoring his own rhetoric
Weather updates: Warnings across South Island, Taranaki, Coromandel, Bay of Plenty
The foods that cancer experts want you to stop eating
Latest review should 'put to bed' methane debate, minister says